Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage

NCT07057817 · tracked via the Priya Life Science Ireland tracker
Phase
Not applicable
Started
2026-01-01
Last updated
2026-07-22

Condition(s) studied

OsteomyelitisDiabetesCalcanectomy

Investigational drug(s) / intervention(s)

Cerament GStandard Surgical Managment

Cerament G: Partial Calcanectomy plus cerament G

Standard Surgical Managment: Partial Calcanectomy as standard of care

Study summary

The ACHILLS Trial is a multicentre randomised controlled feasibility study comparing partial calcanectomy with and without the use of an antibiotic-impregnated bone graft substitute (Cerament G) for treating calcaneal osteomyelitis, specifically on wound healing rates, re-infection, and overall efficacy in a sample of 30 patients over a one-year period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 and over * Undergoing partial calcanectomy * Patients with Type1 or Type 2 Diabetes * Patients will be stratified by Pulse status and eGFR Exclusion Criteria: * Patients unfit for surgery * Patients unable to provide informed consent * Patients with overwhelming sepsis that require major amputation * Patients with hypersensitivity to aminoglycosides * Pre-existing calcium metabolism disorder * Severe renal impairment * Patients in whom major limb amputation is deemed inevitable by the treating physician

Primary outcome measure(s)

  • Rate of Wound Healing — 1 months post-surgery
    To determine the number of patients achieving complete wound healing in patients undergoing treatment with cerament G compared to those with partial calcanectomy alone by measuring wound volume
  • Rate of Wound Healing — 3 months post-surgery
    To determine the number of patients achieving complete wound healing in patients undergoing treatment with cerament G compared to those with partial calcanectomy alone by measuring wound volume
  • Rate of Wound Healing — 6 months post-surgery
    To determine the number of patients achieving complete wound healing in patients undergoing treatment with cerament G compared to those with partial calcanectomy alone by measuring wound volume
  • Rate of Wound Healing — 12 months post-surgery
    To determine the number of patients achieving complete wound healing in patients undergoing treatment with cerament G compared to those with partial calcanectomy alone by measuring wound volume

Trial sites (1)

FacilityCityRegionStatus
University Hospital Galway Galway Ireland Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07057817 on ClinicalTrials.gov ↗ ← All trials in Ireland